Atnaujinkite slapukų nuostatas

Regenerative Therapy Using Blood-Derived Stem Cells 2012 [Kietas viršelis]

Edited by , Edited by
  • Formatas: Hardback, 220 pages, aukštis x plotis: 235x155 mm, weight: 549 g, XII, 220 p., 1 Hardback
  • Serija: Stem Cell Biology and Regenerative Medicine
  • Išleidimo metai: 15-Nov-2011
  • Leidėjas: Humana Press Inc.
  • ISBN-10: 1617794708
  • ISBN-13: 9781617794704
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 220 pages, aukštis x plotis: 235x155 mm, weight: 549 g, XII, 220 p., 1 Hardback
  • Serija: Stem Cell Biology and Regenerative Medicine
  • Išleidimo metai: 15-Nov-2011
  • Leidėjas: Humana Press Inc.
  • ISBN-10: 1617794708
  • ISBN-13: 9781617794704
Kitos knygos pagal šią temą:
Blood has long been viewed as a conduit for therapy, stemming from the ancient days of phlebotomy to remove evil humors to the development of successful blood transfusions to replace missing blood components. The identification and characterization of hematopoietic stem cells by Drs. Till and McCulloch  revolutionized the field and soon after, non-hematopoietic stem and progenitor cells were characterized from the blood and bone marrow. Some of these cell types and various blood-derived cell lineages are involved in the repair of various types of tissue damage that span the spectrum of medical disorders. The goal of this book is to provide an up-to-date review of the various types of blood-derived cells with regenerative capacity, identify opportunities for intervention by examining specific clinical applications, and recognize the regulatory environment that will encompass future therapies in regenerative medicine.

This up-to-date review discusses various types of blood-derived cells with regenerative capacity. The text identifies opportunities for intervention by examining specific clinical applications, and recognizes the regulatory environment that will encompass future therapies in regenerative medicine.
1 Undertaking Regenerative Medicine Studies with Blood Stem Cells
1(8)
Sowmya Viswanathan
Armand Keating
2 Denning Endothelial Progenitor Cells
9(12)
Julie Mund
David A. Ingram
Mervin C. Yoder
3 Blood-Derived ALDHhlCells in Tissue Repair
21(14)
David M. Putman
Gillian I. Bell
David A. Hess
4 Mesenchymal Stem Cells and Tissue Repair
35(18)
Daniel L. Coutu
Moira Francois
Jacques Galipeau
5 Animal Protein-Free Expansion of Human Mesenchymal Stem/Progenitor Cells
53(18)
Katharina Schallmoser
Nathalie Etchart
Dirk Strunk
Eva Rohde
6 Defining Hierarchies of Unrestricted Somatic Stem Cells and Mesenchymal Stem Cells in Cord Blood
71(16)
Gesine Kogler
7 Induced Pluripotent Stem Cells from Blood
87(10)
Ulrich Martin
8 Endothelial Progenitors and Repair of Cardiovascular Disease
97(12)
Benjamin Hibbert
Trevor Simard
Edward R. O'Brien
9 Bone Marrow-Derived Cells as Treatment Vehicles in the Central Nervous System
109(16)
Coral-Ann B. Lewis
Fabio M. Rossi
Charles Krieger
10 Regenerative Potential of Blood Stem Cell Products Used in Hematopoietic Stem Cell Transplantation
125(16)
Laura Labonte
David S. Allan
11 Concepts to Facilitate Umbilical Cord Blood Transplantation
141(16)
Andreas Reinisch
Dirk Strunk
12 Cord Blood Banking for Regenerative Therapy
157(10)
Jennifer Klowak
Yuan Chung
David S. Allan
13 Regulatory Questions in the Development of Blood Stem Cell Products for Regenerative Therapy
167(24)
Michael Rosu-Myles
Liz Anne Gillham-Eisen
Francisca R. Agbanyo
Peter R. Ganz
14 Cell Therapy Regulations from a European Perspective
191(14)
Giani Oancea
Beate Wagner
Reinhard Henschler
15 EBMT Registry of Nonhematopoietic Stem Cells and Regenerative Therapy (Cellular and Engineered Tissue Therapies in Europe)
205(6)
Helen Baldomero
Ivan Marin
Katarina Le Blanc
Jan Cornelissen
Jakob Passweg
Dietger Niederwieser
Index 211
Dr. David S. Allan is a clinician scientist at the Ottawa Hospital Research Institute, affiliated with the Blood & Marrow Transplant Program at the University of Ottawa. His research interests focus of fundamental aspects of vascular progenitor biology and on translational studies in the repair of organ toxicity in patients undergoing hematopoietic stem cell transplantation.

 

Dr. Dirk Strunk is a clinician scientist with the Hematopoietic Stem Cell Transplantation Program and Head of Stem Cell Research at the Medical University of Graz in Austria. His research team develops novel transplantation strategies using mesenchymal stromal cells and endothelial progenitors and has developed animal protein-free methods of cell expansion that facilitate translational studies in humans.